Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Aura Energy #Aura to IPO Swedish Vanadium prospect Watch Here

EXCLUSIVE: Aura Energy #Aura to IPO Swedish Vanadium prospect


Astrazeneca Share Chat (AZN)



Share Price: 5,340.00Bid: 5,340.00Ask: 5,341.00Change: -43.00 (-0.80%)Faller - Astrazeneca
Spread: 1.00Spread as %: 0.02%Open: 5,344.00High: 5,358.00Low: 5,315.00Yesterday’s Close: 5,383.00


Share Discussion for Astrazeneca


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Grayling
Posts: 1,276
Observation
Opinion:Hold
Price:5,342.00
Alzheimers trial failure
12 Jun '18
Great shame that this did not meet expectations, but just underlines the complexity and difficulty of researching and treating this debilitating condition. Still there was no expected financial upside priced in and final year guidance remains unchanged. Let's hope that work continues quietly in the background towards a therapeutic angle for AD.
 
oldabutnowisa
Posts: 846
Off Topic
Opinion:No Opinion
Price:5,478.00
chcscoop11
26 May '18
Agreed but SP close to obvious resistance point. Jump over the 55.00 and we're in new high ground.
chcscoop11
Posts: 19
Off Topic
Opinion:No Opinion
Price:5,436.00
RE: Imfiinzi RNS today is MASSIVE
25 May '18
I hope you're right but c.20bps SP increase seems a bit muted for such great news
oldabutnowisa
Posts: 846
Off Topic
Opinion:No Opinion
Price:5,428.00
Imfiinzi RNS today is MASSIVE
25 May '18
This has repercussions I believe for the MYSTIC trials results to be announced December. If I am correct and those results too are positive, AZN go into orbit. Don't rely on my interpretation. DYOR please but I see £75 as realistic for Xmas in that event. Also great for all our chances of beating lung cancer!!!
Rhambo
Posts: 2,035
Off Topic
Opinion:No Opinion
Price:5,417.00
RE: Happening
21 May '18
fully loaded on pharma atm.... azn....hik....shp.... ripe for US pickings.
oldabutnowisa
Posts: 846
Off Topic
Opinion:No Opinion
Price:5,417.00
Happening
21 May '18
Hello hello! Price reacting rather nicely here. Wonder whether another big pharma is sniffing, scared they really might have a game changer drug worth more too much to leave alone.
easyp
Posts: 904
Observation
Opinion:No Opinion
Price:5,345.00
Interesting
18 May '18
http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=27483114&ArticleHeadline=Friday_preview_All_attention_on_AstraZeneca_and_Hikma_numbers

Remain a watcher but not invested. My money has gone further with OXB this year but remain a fan of the AZN dividend and possibilities.
easyp
Posts: 904
Observation
Opinion:No Opinion
Price:5,279.00
Trump
12 May '18
http://www.lse.co.uk/AllNews.asp?code=eshpe91j&headline=US_President_Trump_Provides_Outline_Of_Plan_To_Reduce_Drug_Prices

Took the dividend and sold due to other commitments and some concerns about Trump.
oldabutnowisa
Posts: 846
Off Topic
Opinion:No Opinion
Price:5,205.00
Q1 Results 18th May
7 May '18
Very interested to see if progress made end of last year in turning this big ship around in terms of profits actually continues and gets stronger end of Q1. Would have the brokers back of fag packet calcs leading to mark-up in SP.
daveycaferacer
Posts: 3,854
Off Topic
Opinion:Strong Buy
Price:4,985.50
Good news for HCM
19 Apr '18
This is great news for HCM who have developed Savolitinib in partnership with AZN and where Savolitinib is just about to commence a Phase 3 study as a combination therapy with Tagrisso - poss BT designation too




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.